Big Pharma Moves to Boston

December 17, 2014 | Big pharma is expanding its reach in the Boston area, picking up small to mid-sized biotechs for billions of dollars. Last week Merck announced plans to buy Cubist Pharmaceuticals for $9.5 billion, following the lead of Pfizer, Novartis, Sanofi, and others before. With space getting tight, the trend could have an impact on research and the talent search. Boston Globe